Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Two Sigma Impact is a mission-driven private equity business within Two Sigma focused on workforce impact rather than drug development or healthcare products. It seeks to combine active ownership, data science, and technology resources to invest in companies where improving job quality and employee experience can drive stronger business performance and positive social outcomes. The business was launched in late 2020 and closed its inaugural impact fund in 2023 with approximately $677 million in capital commitments. Its stated investment thesis is that better jobs can create better companies, particularly in services businesses, and it uses the Good Job Score Assessment Tool as a core analytical framework. Two Sigma Impact is therefore an impact-oriented investment platform, not a biotech, pharma, or healthcare operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Two Sigma Impact.